Gériatrie et Psychologie Neuropsychiatrie du Vieillissement
MENUBleeding complications with oral anticoagulants in the elderly: an observational study Volume 14, issue 4, Décembre 2016
Authors
1 Service de pharmacie, CHU Charleroi - Hôpital André Vésale, Montigny-le-tilleul, Belgique
2 Laboratoire de médecine expérimentale, CHU Charleroi - Hôpital André Vésale, Montigny-le-tilleul, Belgique
3 Service de gériatrie, CHU Charleroi - Hôpital André Vésale, Montigny-le-tilleul, Belgique
* Tirés à part
- Key words: new oral anticoagulants, vitamin K antagonists, bleeding, elderly
- DOI : 10.1684/pnv.2016.0615
- Page(s) : 406-12
- Published in: 2016
Over recent years, new oral anticoagulant agents (NOAC) have been commercialized as a new treatment in order to prevent or treat thromboembolic events. Although the use of NOACs is easier than for vitamin K antagonists (VKA), their risk-benefit balance still raises concerns, especially in the elderly.